Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Thumbnail

Abbott implantable heart failure monitor gains expanded FDA approval

An estimated 1.2 million additional patients are now candidates for the company's small CardioMEMs HF monitor. 

Photon-counting CT boosts image quality and reader confidence in identifying coronary artery disease

The approach outperformed an energy-integrating detector dual-layer CT system and significantly improved image quality, according to a study published in Radiology.

The Vektor Medical vMap system takes standard 12-lead ECGs and converts them into detailed electro anatomical maps for us in catheter ablation procedures.

Electrophysiologists debut new technology that builds interactive cardiac maps out of 12-lead ECGs

The solution, which gained FDA clearance in November 2021, is now being used by specialists at the University of California San Diego Health.

The Freezor Cardiac Cryoablation Catheters

FDA expands two Medtronic cardiac cryoablation catheters for AVNRT

The two single-use devices are now approved for the treatment of pediatric AVNRT.

A dedicated Cardiac MRI scanner. The presence of myocardial fibrosis on cardiac MRI can help anticipate adverse arrhythmic events and  may offer a way to improve patient selection for cardiac implantable electronic devices (CIEDs). This is a dedicated cardiac MRI system at Baylor Scott White.

Cardiac MRI a powerful tool for predicting sudden cardiac death, arrhythmia after CIED implantation

The study's authors suspect their findings could improve patient selection for CIEDs. 

healthcare value value-based care money dollar

Boston Scientific finalizes acquisition of Baylis Medical with $1.75B payment

The deal, first announced in October 2021, expands Boston Scientific’s structural heart disease and electrophysiology portfolios by a significant margin. 

Part of the cath lab case report from Fujifilm Synapse Cardiovascular. This CVIS was ranked Best in KLAS in 2022 based on user interviews.

Best of KLAS 2022: The top cardiovascular information systems and hemodynamic solutions

KLAS Research released its 2022 Best in KLAS report, which includes cardiovascular information systems and hemodynamic systems. 

Ticagrelor alone after DAPT lowers bleeding risk among heart attack patients undergoing PCI

Researchers examined data from the TWILIGHT study to track how different treatment strategies can impact 12-month PCI outcomes.